Total Funding
4
Total FundingPost-IPO Debt raised
Growth Score in past quarter
pts
Heat Score 4 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4099352
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Acquired by 
Savara Pharmaceuticals
About the Company
(NYSE MKT: MSTX) We are a San Diego-based biopharmaceutical company developing proprietary product candidates to treat various diseases and conditions.

